Suven Life Sciences Ltd Financials Statements

Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

Consolidate
Standalone
Financial Year
Mar '25
Dec '24
Sep '24
Jun '24
Mar '24
Total Qtr Revenue cr
2.69
3.24
6.61
5.01
6.67
Other Income Qtr Cr1.221.634.044.014.28
Operating Revenues Qtr1.471.612.571.012.39

*All values are in Cr.

Operating Expenses Qtr
45.29
40.82
54.78
31.54
32.67
Operating Profit Qtr
-43.82
-39.21
-52.21
-30.54
-30.29
EBITDA Qtr Cr
-42.60
-37.58
-48.17
-26.53
-26.00
Depreciation Qtr
1.35
1.53
1.46
1.49
1.51
Net Profit Qtr
-43.94
-39.12
-49.64
-28.04
-26.54
Basic EPS Qtr
-2.02
-1.79
-2.27
-1.29
-1.22
Open Demat Account
+91 -

personImage
Open Demat Account
+91 -